Table 1.
National coordination, monitoring, prevention, screening and treatment policies reported for hepatitis B and hepatitis C in study countries (N=25)
| 2016 | 2017 | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Do not know | Yes | No | Do not know | |||
| National coordination | ||||||||
| Written national HBV strategy | 8 (32%) | 17 (68%) | 0 | 7 (28%) | 18 (72%) | 0 | ||
| Written national HCV strategy | 11 (44%) | 14 (56%) | 0 | 12 (48%) | 13 (52%) | 0 | ||
| Government collaborates with in‐country civil society groups to plan and carry out its viral hepatitis programmea | 13 (52%) | 9 (36%) | 3 (12%) | 18b (75%) | 5b (21%) | 1b (4%) | ||
| Government or government‐ related institution has national HBV disease register | 9 (36%) | 16 (64%) | 0 | 9 (36%) | 15 (60%) | 1 (4%) | ||
| Government or government‐ related institution has national HCV disease register | 11 (44%) | 14 (56%) | 0 | 11 (44%) | 14 (56%) | 0 | ||
| Prevention | ||||||||
| Harm reduction services available: Needle and syringe programmes (all parts of country, some parts of country) | All: 10 (40%) | Some: 10 (40%) | 4 (16%) | 1 (4%) | All: 8 (32%) | Some: 12 (48%) | 3 (12%) | 2 (8%) |
| Harm reduction services available: Opioid substitution therapy (all parts of country, some parts of country) | All: 22 (88%) | Some: 1 (4%) | 0 | 2 (8%) | All: 20 (80%) | Some: 4 (16%) | 0 | 1 (4%) |
| Harm reduction services available: Drug consumption rooms (all parts of country, some parts of country) | All: 2 (8%) | Some: 2 (8%) | 17 (68%) | 4 (16%) | All: 1 (4%) | Some: 5 (20%) | 16 (64%) | 3 (12%) |
| Screening | ||||||||
| Risk assessment for HBV/HCV included in routine medical check‐ups | 5 (20%) | 20 (80%) | 0 | 6 (24%) | 18 (72%) | 1 (4%) | ||
| Liver enzyme testing included in routine medical check‐ups | 17 (68%) | 8 (32%) | 0 | 14 (56%) | 10 (40%) | 1 (4%) | ||
| Treatment | ||||||||
| HBV treatment provided in prisons | 18c (75%) | 5c (21%) | 1c (4%) | 19 (76%) | 5 (20%) | 1 (4%) | ||
| HCV patients have option to be treated in non‐hospital settingsd | 5 (20%) | 20 (80%) | 0 | 5 (20%) | 20 (80%) | 0 | ||
HBV, hepatitis B virus; HCV, hepatitis C virus.
a
Survey respondents were advised that the following are not considered in‐country civil society groups: United Nations agencies, international non‐governmental organizations, government ministries, university programmes and military programmes.
b
2017 responses to this question total 24 instead of 25 because there was one non‐response.
c
2016 responses to this question total 24 instead of 25 because there was one non‐response.
d
Settings that are not within either inpatient or outpatient hospital facilities.